A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
52 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hku Eye Centre
Hong Kong, Hong Kong
- Chinese University of Hong Kong Eye Centre
Kowloon, Hong Kong
- Shivam Retina Clinic and Eye Hospital
Surat, Gujarat, India
- Nethra Eye Hospital
Bengaluru, Karnataka, India
- Amrita Institute of Medical Sciences & Research Centre
Kochi, Kerala, India
- Sarakshi Netralaya
Nagpur, Maharashtra, India
- L V Prasad Eye Institute
Bhubaneswar, Odisha, India
- Icare Eye Hospital & Post Graduate Institute
Noida, Uttar Pradesh, India
- Changhua Christian Hospital
Changhua, Changhua, Taiwan
- China Medical University Hospital
Taichung, Taichung, Taiwan
- Taipei Veterans General Hospital
Taipei, Taipei, Taiwan
- Chang Gung Memorial Hospital
Taoyuan, Taoyuan, Taiwan
- Arizona Retina and Vitreous Consultants
Phoenix, Arizona, United States
- Phoenix Retina Associates
Phoenix, Arizona, United States
- Retina Partners of Northwest Arkansas
Springdale, Arkansas, United States
- Retina-Vitreous Associates Medical Group
Beverly Hills, California, United States
- the Retina Partners
Encino, California, United States
- Retinal Consultants Medical Group
Modesto, California, United States
- California Eye Specialists Medical Group
Pasadena, California, United States
- California Eye Specialists Medical Group
Redlands, California, United States
- Retina Consultants of Southern California
Redlands, California, United States
- California Retina Consultants
Santa Maria, California, United States
- Retina Group of New England
Waterford, Connecticut, United States
- Rand Eye Institute
Deerfield Beach, Florida, United States
- Florida Retina Institute
Jacksonville, Florida, United States
- Medeye Associates
Miami, Florida, United States
- Florida Retina Institute
Orlando, Florida, United States
- Retina Care Specialists
Palm Beach Gardens, Florida, United States
- East Florida Eye Institute
Stuart, Florida, United States
- Southeast Retina Center
Augusta, Georgia, United States
- Retina Associates
Elmhurst, Illinois, United States
- University Retina
Lemont, Illinois, United States
- Midwest Eye Institute
Carmel, Indiana, United States
- Cumberland Valley Retina Consultants
Hagerstown, Maryland, United States
- Retina Consultants of Minnesota
Saint Louis Park, Minnesota, United States
- the Retina Institute
St Louis, Missouri, United States
- Retina-Vitreous Surgeons of Central New York
Liverpool, New York, United States
- North Carolina Retina Associates
Wake Forest, North Carolina, United States
- Velocity (meridian) Clinical Research
Cincinnati, Ohio, United States
- Verum Research Llc
Eugene, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Oct 2021
- Primary completion
- 10 Apr 2026
- Completion
- 10 Apr 2026
- Last update posted
- 5 May 2026
- Registered enrollment
- 552
- Registry id
- NCT05066997
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.